AAP News Vol. 13 No. 7 July 1997, p. 31
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 Previous Articlearrow gif

Ephedrine warnings proposed

The Food and Drug Administration (FDA) is proposing a limit on the amount of ephedrine alkaloids put in dietary supplements because of associated health risks.

The proposal calls for warnings on labels, but would not ban dietary supplements containing ephedrine alkaloids.

Ephedrine alkaloids, sold primarily for weight loss, increased energy and body building, are amphetamine-like compounds with stimulant effects on the nervous system and heart. More than 800 reports of adverse effects associated with the use of these products have been reported.